Skip to main content
Log in

Anthrax

  • Special Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2002

Abstract

Anthrax is caused byBacillus anthracis, an encapulated and spore-forming bacillus. The disease is usually contracted through uptake of spores that remain viable in the contaminated soil for many years. Anthrax is primarily a disease of herbivorous animals and is uncommon in humans who may get the infection through contact with contaminated animals or their products. Anthrax spores germinate after entering the body through skin abrasions (cutaneous anthrax) or by inhalation (inhalation anthrax) or ingestion (gastrointestinal anthrax) and multiply to produce two exotoxins which determine the virulence along with capsule. Although most cases occur within 48 hours of exposure, germination of spores may occur upto 60 days later. While inhalation anthrax is almost always fatal, intestinal anthrax results in death in 25% to 60% of cases. Upto 20% of cases having cutaneous anthrax may die. Antibiotics are effective if the disease is recognised early and treated appropriately. Penicillin is the drug of choice when disease occurs in natural setting. Ciprofloxacin is recommended when aerosols of anthrax spores are used as bioweapon, prophylactic antibiotics should not be prescribed until risk of exposure is considered real by experts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brachman PS, Friedlander AM. Anthrax. In Plotkin SA, Orenstein WA, eds.Vaccines. 3rd edn. Philadelphia: W.B. Saunders Company, 1999, 629–627.

    Google Scholar 

  2. Brachman PS, Kaufmann AF. Anthrax. In Evans AS, Brachman PS, eds.Bacterial Infections of Humans. 3rd edn. New York: Plenum Medical Book Company, 1998; 95–107.

    Google Scholar 

  3. World Health Organization. Health Aspects of Chemical and Biological Weapons. Geneva, Switzerland: WHO; 1970: 98–99.

    Google Scholar 

  4. Office of the Technology Assessment, US Congress. Proliferation of Weapons of Mass Destruction. Washington DC: US Government Printing Office; 1993: 53–55. Publication OTA-ISC-559.

    Google Scholar 

  5. Meselson M. Guillemin J, Hugh-Jones Met al. The Sverdlovsk Anthrax outbreak of 1979. Science 1994; 266: 1202–1208.

    Article  PubMed  CAS  Google Scholar 

  6. Public Health Service Office of the Emergency Preparedness. Proceedings of the Seminar on Responding to the consequences of Chemical and Biological Terrorism. Washington DC: US Department of Health and Human Services, 1995

    Google Scholar 

  7. WuDunn S, Miller J, Broad W. How Japan germ terror alerted world. New York Times. May 26; 1998 : 1–6.

  8. CDC. Update: Investigation of Bioterrorism related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.MMWR 2001; 50: 941–948.

    Google Scholar 

  9. WHO. Anthrax, United States of America (update). Weekly Epidemiological Record 2001; 76: 48–373-380.

    Google Scholar 

  10. Swartz MN. Recognition and management of anthrax-an update. NEJM 2001; 345: 1621–1626.

    Article  PubMed  CAS  Google Scholar 

  11. Inglesby TV, Henderson DA, Bartlett JGet al. Anthrax as a Biological Weapon.JAMA 1999; 281: 1735–1745.

    Article  PubMed  CAS  Google Scholar 

  12. Agarwal SP, Datta KK, Ichhpujani RLet al, eds. Bioterrorism-Public health system to remain alert. CD Alert September-October 2001; 5 : 1–16.

  13. World Health Organization. WHO Recommended Surveillance Standards, WHO Document: WHO/CDS/CSR/ ISR/99.2

Download references

Author information

Authors and Affiliations

Authors

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF02859370.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Datta, K.K., Singh, J. Anthrax. Indian J Pediatr 69, 49–56 (2002). https://doi.org/10.1007/BF02723777

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02723777

Key words

Navigation